ArticleInternational journal of urology : official journal of the Japanese Urological Association2026
Efficacy and Safety of Enfortumab Vedotin by Trial Eligibility in Advanced Urothelial Carcinoma: A Multicenter Real-World Study.
Naoto Wakita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.